通过系统性免疫调节,DPSC-EVs通过系统性免疫调节驱动Sjögren病的功能恢复
Tatsuya Kawado1, Kenichi Ogata1,2, Masafumi Moriyama3
1Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
牙髓干细胞外细胞囊泡 (DPSC-EVs) 显示出对Sjögren病 (SjD) 的治疗有前途. 一次DPSC-EV剂量改善了唾液功能,并通过调节中的免疫细胞来减少炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 斯约格伦病 (SjD) 导致唾液腺破坏,只有有限的息治疗.
- 对SjD需要免疫调节疗法.
- 来自牙髓干细胞 (DPSC-EVs) 的细胞外囊泡提供了一个无细胞的治疗方法.
研究的目的:
- 在SjD小鼠模型中研究DPSC-EVs的治疗疗效.
- 为了比较DPSC-EVs与骨髓衍生的EVs (BMMSC-EVs).
- 为了阐明DPSC-EV免疫调节的机制.
主要方法:
- 将DPSC-EV和BMMSC-EV给一个非肥胖的糖尿病小鼠SjD模型.
- 评估唾液腺功能,自身抗体和炎症.
- 在体内跟踪DPSC-EV并分析巨细胞相互作用和信号通路.
主要成果:
- DPSC-EV显著恢复了唾液腺功能,并减少了炎症和自身抗体.
- DPSC-EVs优先积聚在脏中,并被巨细胞内化.
- 通过TGF-β1传输和NEDD4L下调,DPSC-EVs诱导了TGF-β/Smad信号的双调制.
结论:
- DPSC-EVs代表了一种有前途的无细胞治疗SjD.
- 治疗效果是由脏巨细胞调节TGF-β/Smad信号传递的介导.
- DPSC-EVs为SjD治疗中的临床转化提供了潜在的途径.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
相关概念视频
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
EPS and iPS Cells in Disease Research
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
iPS Cell Differentiation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
